Raising the standard for hair
loss research
clinical trials
The first Phase 3 trials for an oral therapy in nearly 30 years.
Veradermics is currently pursuing three multi-center, randomized, double-blind, placebo-controlled studies evaluating the safety and efficacy of VDPHL01, the potential first non-hormonal oral pill for pattern hair loss, in both men and women.
Our clinical program includes:
Large, randomized
Phase 3 trials
With aim to study 1500 men and women with pattern hair loss.
Dedicated studies for
both men and women
First ever Phase 3 trial for female pattern hair loss.
Rigorous clinical
endpoints
Focused on measuring visible hair regrowth.
pipeline
Current VDPHL01 Clinical Trials
01
Study 302
Phase 2/3 trial evaluating VDPHL01 in males with pattern hair loss
Phase 3 registration-directed study in males- Parallel in-trial Phase 2 component to further assess patient reported outcome (PRO) endpoints in Studies 302 & 304
- Fully enrolled with 6-month topline Phase 2/3 readout anticipated in H1 2026
02
Study 304
Phase 3 trial evaluating VDPHL01 in males with pattern hair loss
- Confirmatory Phase 3 registration- directed study in males
- Fully enrolled with 6-month topline Phase 3 readout anticipated in H2 2026
03
Study 306
Phase 2/3 trial evaluating VDPHLO1 in females with pattern hair loss
- Phase 3 registration-directed study in females
- Parallel in-trial Phase 2 component to further assess PRO endpoints in the Phase 3 portion of the study.
- Study is actively enrolling
Beyond VDPHL01, we have utilized our real-world experience as dermatologists to generate a compelling portfolio of pipeline assets including exploratory assets in alopecia areata, common warts, and molloscum contagiosum, that may be advanced in the future.
clinical trials underway
Now enrolling females
with pattern hair loss
We are currently enrolling female participants in the first Phase 2/3 national clinical trial for women with pattern hair loss to evaluate our lead product candidate, VDPHL01, the potential first-ever, extended-release, oral minoxidil for hair growth.
For more information and to find a study site:
